Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a
global population of more than 35 million people living with HIV, there is intense interest in …

Therapeutic strategies are being clinically tested either to eradicate latent HIV reservoirs or
to achieve virologic control in the absence of antiretroviral therapy. Attaining this goal will …

Persistent HIV-1 replication during antiretroviral therapy : Current Opinion in HIV and AIDS
Persistent HIV-1 replication during antiretroviral therapy : Current Opinion in HIV and AIDS Log …

Long-term delivery of anti-HIV monoclonal antibodies (mAbs) using adeno-associated virus
(AAV) vectors holds promise for the prevention and treatment of HIV infection. We describe a …

ABSTRACT A disease of more than 39.6 million people worldwide, HIV-1 infection has no
curative therapy. To date, one man has achieved a sterile cure, with millions more hoping to …

Objective To characterize the evolution of central nervous system (CNS) inflammation in HIV-
1 infection applying a panel of cerebrospinal fluid (CSF) inflammatory biomarkers to …

Antibody profiles have the potential to revolutionize personalized medicine by providing
important information related to autoimmunity against self-proteins and exposure to …

Objective: The eradication of HIV necessitates elimination of the HIV latent reservoir.
Identifying host determinants governing latency and reservoir size in the setting of …

Background. Human immunodeficiency virus (HIV) antibodies are generated and
maintained by ongoing systemic expression of HIV antigen. We investigated whether HIV …

Global antibody glycosylation is dynamic and plays critical roles in shaping different
immunological outcomes and direct antibody functionality during HIV infection. However, the …